Advert - Roche – Case AUTH/3646/5/22

• Date posted
  18 October 2023
• Sanction
  Advertisement,
• Case number/s
  AUTH/3646/5/22 - Complainant v Roche

For omitting important safety information from the dosing webpage of the Rozlytrek (entrectinib) promotional website that a health professional would expect to have been made aware of on such a webpage, Roche was ruled in breach of the following Clauses of the 2021 Code:

Clause 2           - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 5.1        - Failing to maintain high standards

Clause 6.1        - Providing misleading information